10729-1-AP

antibody from Proteintech Group

Targeting: SERBP1 CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

10729-1-AP

Provider

Proteintech Group

Proper citation

Proteintech Cat#10729-1-AP, RRID:AB_2185130

Product name

SERBP1 antibody

Antibody type

Polyclonal

Description

SERBP1 antibody (Cat. #10729-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

SERBP1 is required for efficient HR repair and cisplatin chemoresistance in lung adenocarcinoma.

Xie Y, Chen Q, Tang N, Zeng Y, Zhao J, Yang Y, Li C, Li J, Zhu J, Huang JA, Liu Z
Cell death discovery 2026 Mar 19;12(1)

---

Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation.

El-Brolosy MA, Oak A, Hoang AT, Damergi Y, Fischer A, Saunders RA, Luo J, Balabaki A, Guez J, Whitfield TW, Goldman SR, Latifkar A, Lu YR, Stainier DYR, Karczewski KJ, Corradin O, Weissman JS
Science (New York, N.Y.) 2026 Feb 12;391(6786):eaea1272

---

Investigating the abnormalities and potential therapeutic targets in umbilical cord mesenchymal stem cells from preeclampsia.

He F, Cai W, Cai S, Ou C, Lu S, Huang Z, Li S, Pan S
Placenta 2025 Sep;169:49-59

---

Long-term low-dose exposure to 9-chlorophenanthrene induces liver lipid accumulation via disrupting circadian rhythm.

Liu M, Lu Y, Zhou H, Chen Y, Li Y, Zhang T
Journal of hazardous materials 2025 Sep 5;495:139145

---

The role of cell surface RNAs in hepatocellular carcinoma.

He J, Jiang H, Wang Y, Su X, Zhang H, Zhang D
International journal of biological macromolecules 2025 Nov;330(Pt 3):147948

---

Super-enhancer-driven ELOVL5 promotes T-ALL progression through the MYC-SERBP1 pathway.

Zhang S, Cheng W, Li T, Zhang Z, Yu J, Jiao W, Wan X, Wu Y, Xu L, Ji T, Yang Y, Pan J, Lu J
Genomics 2025 Nov;117(6):111111

---

SERBP1-PCIF1 complex-controlled m6Am modification in glutamatergic neurons of the primary somatosensory cortex is required for neuropathic pain in mice.

Huang Y, Ma G, Xie S, Wei R, Liu Y, Zeng Y, Zhao Y, Wang Q, Yang L, Huang H, Hao L, Zhao X, Wang H, Shen W, Wong SSC, Cao JL, Tao YX, Pan ZQ
Nature communications 2025 Aug 5;16(1):7225

---

Identification of immune signatures in Parkinson's disease based on co-expression networks.

Dong X, Li Y, Li Q, Li W, Wu G
Frontiers in genetics 2023;14:1090382

---

Triggering endogenous Z-RNA sensing for anti-tumor therapy through ZBP1-dependent necroptosis.

Yang T, Wang G, Zhang M, Hu X, Li Q, Yun F, Xing Y, Song X, Zhang H, Hu G, Qian Y
Cell reports 2023 Nov 28;42(11):113377

---

The HMGA2-IMP2 Pathway Promotes Granulosa Cell Proliferation in Polycystic Ovary Syndrome.

Li M, Zhao H, Zhao SG, Wei DM, Zhao YR, Huang T, Muhammad T, Yan L, Gao F, Li L, Lu G, Chan WY, Leung PCK, Dunaif A, Liu HB, Chen ZJ
The Journal of clinical endocrinology and metabolism 2019 Apr 1;104(4):1049-1059